Cracking China’s market – via Taiwan – Neurovive moves to take Asian subsidiary public
TAIPEI, TAIWAN – Neurovive Pharmaceutical AB’s Hong Kong-registered subsidiary, Neurovive Pharmaceutical Asia Ltd., has signed a financial services agreement with Yuanta Securities Co. Ltd. for the Taiwanese company to be its underwriter in a planned initial public offering (IPO) in Taiwan.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST